Eyestem moves closer to blindness breakthrough with phase 2 trial green light
The early-stage trial demonstrated an excellent safety profile alongside clinically meaningful improvements in visual acuity
The early-stage trial demonstrated an excellent safety profile alongside clinically meaningful improvements in visual acuity
Subscribe To Our Newsletter & Stay Updated